BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T083000
DTEND;TZID=Europe/London:20260710T183000
DTSTAMP:20260521T204300
CREATED:20260515T122254Z
LAST-MODIFIED:20260515T122254Z
UID:10002246-1783672200-1783708200@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Industry MasterClass in Drug Discovery and Development
DESCRIPTION:Taking therapeutics for neurodegeneration from concept to trial \nJoin leading experts from academia\, biotech\, pharma and drug development for a practical one day MasterClass exploring how discoveries in neurodegeneration can move from early target selection through to clinical trial strategy. \nThis in person event will examine the key stages of the drug discovery and development process\, from identifying and validating targets\, discovering and optimising leads\, and navigating regulatory and commercial considerations\, through to preparing for trial delivery. \nThe programme will bring together speakers from organisations including AstraZeneca\, MSD\, Lundbeck\, AbbVie\, Novartis\, Roche\, Eisai\, Cervevance\, Isomorphic\, Denali\, AstronautX\, JNJ\, Advent\, Lilly and BMS. \nDiscussions will be hosted by Prof. Sarah Tabrizi and Prof. Mike Hanna from UCL. \nKeynote\nThe Journey from an Academic Discovery to a TrialKaterina AkassoglouGladstone Institute and Founder\, Therini Bio \nCo organisers\nFiona DucotterdAlzheimer’s Research UK UCL Drug Discovery Institute \nJim RayBelfer Neurodegeneration Consortium\, MD Anderson \nWhat will be covered\nAttendees will discuss: \n\nHow targets are selected to progress in biotech and pharma\nHow leads are discovered and optimised into therapeutics\nHow discoveries move from hit to candidate to formulation\nHow regulatory and commercial considerations are navigated\nHow to move towards a clinical trial\nHow value is created for patients\, providers and the pharmaceutical industry\nWhere the field is heading next\n\nEvent details\nDate: Friday 10 July 2026Time: 8.30 am to 6.30 pmLocation: Mary Ward House\, LondonFormat: In personCapacity: Limited places available \nWho should attend\nThis MasterClass is designed for researchers\, clinicians\, industry professionals\, funders\, translational scientists and anyone interested in how neurodegeneration therapeutics move from discovery science towards development and trial readiness. \nRegistration is now open.A practical\, high level course on translating neurodegeneration drug discovery into development strategy.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/industry-masterclass-in-drug-discovery-and-development/
LOCATION:Mary Ward House\, 5 - 7 Tavistock Place\, London\, Greater London\, WC1H 9SN\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/UCL-Logo.png
END:VEVENT
END:VCALENDAR